Maquette de la nouvelle usine de Green Cross Biotherapeutics, Montréal, Québec
CLIENT

GRIFOLS (GCBT)

PROJECT

New 300,000 sq. ft. plasma fractionation plant

 

Construction of a new plasma fractionation facility in order to produce daily batches of 4,000 liters of plasma per day for a total of approximately 1,000,000 liters per year, for the production of albumin and intravenous immunoglobulin (IVIG-SM). The facility has been designed and built to meet the requirements of cGMP in Canada and the USA, and be compliant with blood product US-FDA and Health Canada regulatory requirements.

MANDATE

Construction management

 

LOCATION

Montreal, Quebec

 

SECTOR

Pharmaceutical and biotechnology

Grifols-logo
Green Cross
Category
Pharmaceutical